Published • loading... • Updated
Pillar Biosciences Announces Final CMS Pricing Determination for oncoReveal® CDx
Summary by Clearwater Progress
4 Articles
4 Articles
+3 Reposted by 3 other sources
Pillar Biosciences Announces Final CMS Pricing Determination for oncoReveal® CDx
NATICK, Mass., Dec. 1, 2025 /PRNewswire/ -- Pillar Biosciences, the leader in Decision Medicine™, today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized its pricing determination for oncoReveal CDx. Following its preliminary decision in August 2025,…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium


